Vosoritide Aids Growth in Achondroplasia
(MedPage Today) -- The C-type natriuretic peptide analogue vosoritide significantly increased growth velocity in children with achondroplasia, a phase III trial found.
Among 119 children who completed 52 weeks of daily subcutaneous vosoritide...
Read more »